Clinical Trial

A Study of GensSci098 in Subjects With Graves' Disease

Name: A Study of GensSci098 in Subjects With Graves' Disease — clinical trial record (NCT07286656)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of single ascending subcutaneous doses of GenSci098 in patients with Graves' Disease

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-03.

Status change: Not Yet Recruiting → Recruiting 2026-02-13

Trial Details

NCT Number	NCT07286656
Lead Sponsor	Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions	Safety, Tolerability, GenSci098, Graves Disease
Enrollment	24 participants
Start Date	2025-11-21
Primary Completion	2026-10-28 (estimated)
Study Completion	2027-03-18 (estimated)
Updated on ClinicalTrials.gov	2026-02-17